|
1
|
Liang B, Li Y and Wang T: A three miRNAs
signature predicts survival in cervical cancer using bioinformatics
analysis. Sci Rep. 7:56242017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pimple S, Mishra G and Shastri S: Global
strategies for cervical cancer prevention. Curr Opin Obstet
Gynecol. 28:4–10. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li H, Wu X and Cheng X: Advances in
diagnosis and treatment of metastatic cervical cancer. J Gynecol
Oncol. 27:e432016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bahrami A, Hasanzadeh M, Shahidsales S,
Farazestanian M, Hassanian SM, Moetamani Ahmadi M, Maftouh M,
Gharib M, Yousefi Z, Kadkhodayan S, et al: Genetic susceptibility
in cervical cancer: From bench to bedside. J Cell Physiol.
233:1929–1939. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guido R: Cervical cancer screening. Clin
Obstet Gynecol. 61:40–51. 2018.PubMed/NCBI
|
|
8
|
Clough E and Barrett T: The gene
expression omnibus database. Methods Mol Biol. 1418:93–110. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chandran UR, Medvedeva OP, Barmada MM,
Blood PD, Chakka A, Luthra S, Ferreira A, Wong KF, Lee AV, Zhang Z,
et al: TCGA expedition: A data acquisition and management system
for TCGA data. PLoS One. 11:e01653952016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park S, Eom K, Kim J, Bang H, Wang HY, Ahn
S, Kim G, Jang H, Kim S, Lee D, et al: MiR-9, miR-21, and miR-155
as potential biomarkers for HPV positive and negative cervical
cancer. BMC Cancer. 17:6582017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oliveira CA, Russomano FB, Gomes Júnior SC
and Corrêa Fde M: Risk of persistent high-grade squamous
intraepithelial lesion after electrosurgical excisional treatment
with positive margins: A meta-analysis. Sao Paulo Med J.
130:119–125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Q, Su YL and Shen WX: A novel
prognostic signature of seven genes for the prediction in patients
with thymoma. J Cancer Res Clin Oncol. 145:109–116. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hou C, Zhuang Z, Deng X, Xu Y, Zhang P and
Zhu L: Knockdown of Trio by CRISPR/Cas9 suppresses migration and
invasion of cervical cancer cells. Oncol Rep. 39:795–801.
2018.PubMed/NCBI
|
|
14
|
Li W, Liang J, Zhang Z, Lou H, Zhao L, Xu
Y and Ou R: MicroRNA-329-3p targets MAPK1 to suppress cell
proliferation, migration and invasion in cervical cancer. Oncol
Rep. 37:2743–2750. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Di J, Rutherford S and Chu C: Review of
the cervical cancer burden and population-based cervical cancer
screening in China. Asian Pac J Cancer Prev. 16:7401–7407. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Farzaneh E, Heydari H, Shekarchi AA and
Kamran A: Breast and cervical cancer-screening uptake among females
in Ardabil, northwest Iran: A community-based study. Onco Targets
Ther. 10:985–992. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Moyer VA; U.S. Preventive Services Task
Force, : Screening for cervical cancer: U.S. Preventive Services
Task Force recommendation statement. Ann Intern Med. 156:880–891.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huh WK, Ault KA, Chelmow D, Davey DD,
Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D,
et al: Use of primary high-risk human papillomavirus testing for
cervical cancer screening: Interim clinical guidance. Obstet
Gynecol. 125:330–337. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nakada T, Akiba T, Yabe M, Tanaka K,
Nakano M, Suzuki M and Morikawa T: Clinicopathological features of
thymoma with ring calcification: Case reports. Ann Thorac
Cardiovasc Surg. 23:256–261. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim HY: The methionine sulfoxide reduction
system: Selenium utilization and methionine sulfoxide reductase
enzymes and their functions. Antioxid Redox Signal. 19:958–969.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee E, Kwak GH, Kamble K and Kim H:
Methionine sulfoxide reductase B3 deficiency inhibits cell growth
through the activation of p53-p21 and p27 pathways. Arch Biochem
Biophys. 547:1–5. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kwak GH and Kim HY: MsrB3 deficiency
induces cancer cell apoptosis through p53-independent and ER
stress-dependent pathways. Arch Biochem Biophys. 621:1–5. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kwak GH, Kim TH and Kim HY:
Down-regulation of MsrB3 induces cancer cell apoptosis through
reactive oxygen species production and intrinsic mitochondrial
pathway activation. Biochem Biophys Res Commun. 483:468–474. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu C, Zhang W, Yang D and Liu Y:
Molecular characterization, polymorphism, and association of
porcine GADD45G Gene. Anim Biotechnol. 26:230–236. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Oliveras-Ferraros C, Vazquez-Martin A,
Cuyàs E, Corominas-Faja B, Rodríguez-Gallego E, Fernández-Arroyo S,
Martin-Castillo B, Joven J and Menendez JA: Acquired resistance to
metformin in breast cancer cells triggers transcriptome
reprogramming toward a degradome-related metastatic stem-like
profile. Cell Cycle. 13:1132–1144. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hoischen C, Yavas S, Wohland T and
Diekmann S: CENP-C/H/I/K/M/T/W/N/L and hMis12 but not CENP-S/X
participate in complex formation in the nucleoplasm of living human
interphase cells outside centromeres. PLoS One. 13:e01925722018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sutherland MJ, Wang S, Quinn ME, Haaning A
and Ware SM: Zic3 is required in the migrating primitive streak for
node morphogenesis and left-right patterning. Hum Mol Genet.
22:1913–1923. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lyu Y, Nakano K, Davis RR, Tepper CG,
Campbell M and Izumiya Y: ZIC2 is essential for maintenance of
latency and is a target of an immediate early protein during
Kaposi's sarcoma-associated Herpesvirus lytic reactivation. J
Virol. 91(pii): e00980–17. 2017.PubMed/NCBI
|
|
30
|
Marchini S, Poynor E, Barakat RR, Clivio
L, Cinquini M, Fruscio R, Porcu L, Bussani C, D'Incalci M, Erba E,
et al: The zinc finger gene ZIC2 has features of an oncogene and
its overexpression correlates strongly with the clinical course of
epithelial ovarian cancer. Clin Cancer Res. 18:4313–4324. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Inaguma S, Ito H, Riku M, Ikeda H and
Kasai K: Addiction of pancreatic cancer cells to zinc-finger
transcription factor ZIC2. Oncotarget. 6:28257–28268. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhu P, Wang Y, He L, Huang G, Du Y, Zhang
G, Yan X, Xia P, Ye B, Wang S, et al: ZIC2-dependent OCT4
activation drives self-renewal of human liver cancer stem cells. J
Clin Invest. 125:3795–808. 2015. View
Article : Google Scholar : PubMed/NCBI
|
